Rick Wise
Stock Analyst at Stifel Nicolaus
(0.43)
# 4,058
Out of 4,407 analysts
804
Total ratings
45.6%
Success rate
-2.4%
Average return
Main Sectors:
Stocks Rated by Rick Wise
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDT Medtronic | Maintained: Hold | $95 → $80 | $80.20 | -0.25% | 50 | Jun 3, 2026 | |
| AORT Artivion | Maintained: Buy | $45 | $20.10 | +123.88% | 20 | Jun 1, 2026 | |
| BSX Boston Scientific | Maintained: Buy | $85 → $75 | $46.91 | +59.88% | 65 | May 27, 2026 | |
| HTFL HeartFlow | Maintained: Buy | $40 | $33.24 | +20.34% | 5 | May 15, 2026 | |
| BDX Becton, Dickinson and Company | Maintained: Buy | $215 → $175 | $146.24 | +19.67% | 31 | May 8, 2026 | |
| LMAT LeMaitre Vascular | Maintained: Buy | $115 → $120 | $91.96 | +30.49% | 24 | May 8, 2026 | |
| TSX: PRN Profound Medical Corp. | Rated: Buy | $16.79 → $14.00 | $9.27 | +50.98% | 10 | May 8, 2026 | |
| OM Outset Medical | Rated: Buy | $8 → $6 | $4.46 | +34.68% | 30 | May 8, 2026 | |
| MDLN Medline | Maintained: Buy | $55 → $50 | $36.61 | +36.57% | 3 | May 8, 2026 | |
| ATRC AtriCure | Maintained: Buy | $50 | $28.82 | +73.49% | 34 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $105 → $90 | $78.87 | +14.11% | 11 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $20 → $19 | $20.86 | -8.92% | 36 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $440 → $360 | $312.20 | +15.31% | 34 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $17.82 | +23.46% | 32 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 → $2.5 | $1.37 | +82.48% | 21 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $110 → $105 | $88.57 | +18.55% | 47 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $98 → $80 | $65.18 | +22.74% | 16 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $110 | $85.11 | +29.24% | 50 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $670 | $411.06 | +62.99% | 48 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $145 → $120 | $88.18 | +36.09% | 44 | Apr 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $220 → $250 | $240.87 | +3.79% | 30 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $20.85 | +43.88% | 7 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 | $4.06 | -26.11% | 24 | Mar 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 → $80 | $79.39 | +0.77% | 36 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $17 → $14 | $24.96 | n/a | 32 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $55 | $34.77 | n/a | 32 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1 | $0.000001 | n/a | 8 | Jun 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $25 → $30 | $2.30 | n/a | 13 | Feb 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $25 → $34 | $16.60 | n/a | 9 | Aug 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $560.88 | n/a | 2 | Nov 8, 2012 |
Medtronic
Jun 3, 2026
Maintained: Hold
Price Target: $95 → $80
Current: $80.20
Upside: -0.25%
Artivion
Jun 1, 2026
Maintained: Buy
Price Target: $45
Current: $20.10
Upside: +123.88%
Boston Scientific
May 27, 2026
Maintained: Buy
Price Target: $85 → $75
Current: $46.91
Upside: +59.88%
HeartFlow
May 15, 2026
Maintained: Buy
Price Target: $40
Current: $33.24
Upside: +20.34%
Becton, Dickinson and Company
May 8, 2026
Maintained: Buy
Price Target: $215 → $175
Current: $146.24
Upside: +19.67%
LeMaitre Vascular
May 8, 2026
Maintained: Buy
Price Target: $115 → $120
Current: $91.96
Upside: +30.49%
Profound Medical Corp.
May 8, 2026
Rated: Buy
Price Target: $16.79 → $14.00
Current: $9.27
Upside: +50.98%
Outset Medical
May 8, 2026
Rated: Buy
Price Target: $8 → $6
Current: $4.46
Upside: +34.68%
Medline
May 8, 2026
Maintained: Buy
Price Target: $55 → $50
Current: $36.61
Upside: +36.57%
AtriCure
May 6, 2026
Maintained: Buy
Price Target: $50
Current: $28.82
Upside: +73.49%
May 6, 2026
Maintained: Buy
Price Target: $105 → $90
Current: $78.87
Upside: +14.11%
May 1, 2026
Maintained: Hold
Price Target: $20 → $19
Current: $20.86
Upside: -8.92%
May 1, 2026
Maintained: Buy
Price Target: $440 → $360
Current: $312.20
Upside: +15.31%
May 1, 2026
Reiterated: Buy
Price Target: $22
Current: $17.82
Upside: +23.46%
Apr 30, 2026
Maintained: Buy
Price Target: $5 → $2.5
Current: $1.37
Upside: +82.48%
Apr 29, 2026
Rated: Buy
Price Target: $110 → $105
Current: $88.57
Upside: +18.55%
Apr 29, 2026
Maintained: Buy
Price Target: $98 → $80
Current: $65.18
Upside: +22.74%
Apr 24, 2026
Maintained: Buy
Price Target: $110
Current: $85.11
Upside: +29.24%
Apr 22, 2026
Maintained: Buy
Price Target: $670
Current: $411.06
Upside: +62.99%
Apr 17, 2026
Rated: Buy
Price Target: $145 → $120
Current: $88.18
Upside: +36.09%
Apr 15, 2026
Rated: Hold
Price Target: $220 → $250
Current: $240.87
Upside: +3.79%
Mar 18, 2026
Maintained: Buy
Price Target: $30
Current: $20.85
Upside: +43.88%
Mar 1, 2026
Maintained: Hold
Price Target: $3
Current: $4.06
Upside: -26.11%
Feb 25, 2026
Reiterated: Buy
Price Target: $70 → $80
Current: $79.39
Upside: +0.77%
May 7, 2025
Maintained: Hold
Price Target: $17 → $14
Current: $24.96
Upside: n/a
May 1, 2025
Maintained: Hold
Price Target: $55
Current: $34.77
Upside: n/a
Jun 3, 2023
Maintained: Hold
Price Target: $1
Current: $0.000001
Upside: n/a
Feb 25, 2019
Upgraded: Buy
Price Target: $25 → $30
Current: $2.30
Upside: n/a
Aug 22, 2018
Maintained: Hold
Price Target: $25 → $34
Current: $16.60
Upside: n/a
Nov 8, 2012
Rated: Hold
Price Target: n/a
Current: $560.88
Upside: n/a